Fbxo4 missense mutations occur with a frequency of ~14% in human oesophageal squamous cell carcinoma (ESCC) and 10% in melanoma, accounting for cyclin D1 accumulation and tumorigenesis3, 4. The gene discussed is FBXO4; the disease is melanoma.